Opus Genetics Inc
NASDAQ:IRD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Opus Genetics Inc
NASDAQ:IRD
|
US |
|
Ciputra Development Tbk PT
F:PUWA
|
ID |
|
G
|
GL Pharm Tech Corp
KOSDAQ:204840
|
KR |
|
China Coal Energy Co Ltd
SSE:601898
|
CN |
|
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
US |
|
S
|
Scilex Holding Co
NASDAQ:SCLX
|
US |
|
K Wah International Holdings Ltd
F:KW2
|
HK |
|
Mondi PLC
LSE:MNDI
|
UK |
|
S
|
SPAR Group Ltd
JSE:SPP
|
ZA |
|
Xerox Holdings Corp
NASDAQ:XRX
|
US |
|
Axiata Group Bhd
OTC:AXXTF
|
MY |
|
V
|
Verizon Communications Inc
SWB:BAC
|
US |
Balance Sheet
Balance Sheet Decomposition
Opus Genetics Inc
Opus Genetics Inc
Balance Sheet
Opus Genetics Inc
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
2
|
4
|
4
|
0
|
7
|
12
|
10
|
13
|
19
|
10
|
10
|
12
|
9
|
9
|
9
|
16
|
25
|
43
|
51
|
30
|
45
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
2
|
4
|
4
|
0
|
7
|
12
|
10
|
13
|
19
|
10
|
10
|
12
|
9
|
9
|
9
|
16
|
25
|
43
|
51
|
30
|
45
|
|
| Short-Term Investments |
0
|
1
|
8
|
0
|
4
|
3
|
0
|
2
|
2
|
0
|
0
|
23
|
13
|
9
|
18
|
6
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
6
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
6
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Total Current Assets |
0
|
1
|
10
|
5
|
8
|
4
|
8
|
16
|
12
|
14
|
19
|
33
|
25
|
21
|
28
|
16
|
13
|
18
|
26
|
49
|
54
|
37
|
50
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+917%
|
11
+779%
|
5
-53%
|
8
+70%
|
4
-52%
|
10
+143%
|
16
+62%
|
14
-16%
|
15
+9%
|
20
+31%
|
34
+71%
|
25
-26%
|
21
-15%
|
28
+34%
|
16
-43%
|
13
-19%
|
18
+36%
|
26
+48%
|
49
+88%
|
54
+10%
|
37
-32%
|
50
+36%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
2
|
1
|
2
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
2
|
3
|
1
|
2
|
2
|
1
|
2
|
8
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
0
|
1
|
2
|
1
|
1
|
1
|
2
|
3
|
2
|
3
|
3
|
3
|
3
|
4
|
3
|
4
|
11
|
8
|
|
| Long-Term Debt |
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Liabilities |
0
|
1
|
1
|
1
|
1
|
1
|
4
|
4
|
2
|
5
|
6
|
4
|
3
|
2
|
8
|
2
|
0
|
28
|
0
|
0
|
0
|
0
|
26
|
|
| Total Liabilities |
0
N/A
|
2
+3 480%
|
6
+229%
|
2
-70%
|
2
-3%
|
1
-18%
|
5
+261%
|
6
+14%
|
3
-49%
|
5
+81%
|
7
+29%
|
7
+0%
|
6
-13%
|
4
-34%
|
12
+189%
|
5
-52%
|
3
-45%
|
31
+935%
|
4
-88%
|
3
-29%
|
4
+47%
|
11
+179%
|
35
+209%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
|
| Retained Earnings |
0
|
8
|
14
|
21
|
25
|
30
|
32
|
46
|
57
|
63
|
73
|
91
|
106
|
115
|
140
|
155
|
163
|
33
|
89
|
71
|
81
|
139
|
189
|
|
| Additional Paid In Capital |
0
|
7
|
19
|
24
|
32
|
33
|
37
|
56
|
68
|
73
|
85
|
118
|
124
|
132
|
157
|
165
|
173
|
19
|
112
|
118
|
131
|
146
|
204
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
N/A
|
5
N/A
|
3
-33%
|
7
+110%
|
3
-60%
|
5
+81%
|
10
+112%
|
11
+3%
|
10
-11%
|
13
+33%
|
27
+110%
|
19
-29%
|
17
-9%
|
17
-2%
|
11
-37%
|
10
-6%
|
13
N/A
|
22
N/A
|
46
+108%
|
50
+8%
|
26
-49%
|
15
-40%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+917%
|
11
+779%
|
5
-53%
|
8
+70%
|
4
-51%
|
10
+142%
|
16
+62%
|
14
-16%
|
15
+9%
|
20
+31%
|
34
+71%
|
25
-26%
|
21
-15%
|
28
+34%
|
16
-43%
|
13
-19%
|
18
+36%
|
26
+48%
|
49
+88%
|
54
+10%
|
37
-32%
|
50
+36%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
11
|
19
|
21
|
24
|
32
|
70
|
|